molybdenum cofactor deficiency Type A

View All

merck
BridgeBio bags $299M; Immunochina receives $20M; Attune raises; Wren receives $23M

BridgeBio bags USD 299 Million for genetic diseases BridgeBio Pharma has received a USD299.2 million for its progress in genetic disease pipeline. This includes assets in preclinical and clinical development. Several therapeutic areas are being taken under the consideration of the pharma. Also, th...

Find More